Ellanse M (2 x 1ml)
$285.00
Ellansé M Collagen-Stimulating Dermal Filler is an FDA-approved injectable containing 30% PCL microspheres and 70% CMC gel. Clinically proven to reduce wrinkles and restore facial volume, it provides immediate correction while stimulating natural collagen production for 18-24 months. 92% of users achieve visible results within 4 weeks, ideal for cheekbones, nasolabial folds, and jawline contouring with minimal downtime.
Out of stock
Ellansé M Collagen-Stimulating Dermal Filler
Biodegradable collagen-stimulating injectable for long-lasting facial rejuvenation
Advanced Collagen-Stimulating Technology
FDA-approved biodegradable dermal filler containing 30% Polycaprolactone (PCL) microspheres in 70% carboxymethylcellulose gel. Clinically proven to stimulate natural collagen production for long-lasting facial rejuvenation.
Provides immediate volume correction with 92% of subjects achieving visible results within 4 weeks and 18-24 month longevity (3x longer than HA fillers). Ideal for mid-deep dermis injection to enhance cheekbones, nasolabial folds and jawline contour.
Key Clinical Benefits
Collagen Stimulation
Stimulates natural Type I collagen synthesis
Long-Lasting Results
Clinically proven 18-24 month longevity
Immediate Correction
Visible results in 92% of subjects within 4 weeks
Minimal Downtime
Optimized for facial contours with rapid recovery
Advanced PCL Technology
Dual-Action Mechanism
Ellansé M provides immediate volume restoration through its CMC gel carrier while the PCL microspheres gradually stimulate natural collagen production over 12-24 months. The microspheres integrate naturally with tissue architecture, providing a scaffold for new collagen formation.
Biodegradable & Biocompatible
The PCL microspheres are completely biodegradable and biocompatible. They undergo hydrolysis into carbon dioxide and water, which are naturally metabolized by the body, ensuring safety and predictable outcomes over the treatment cycle.
Packaging Specifications
Composition
- 30% Polycaprolactone (PCL) microspheres (25-50 μm size)
- 70% carboxymethylcellulose (CMC) carrier gel
- Concentration: 100 mg/ml
Storage & Handling
- Packaging: 2 × 1ml sterile prefilled syringes
- Storage Temperature: 2°C to 25°C
- Shelf Life: 36 months in original packaging
Clinical Administration Protocol
Pre-Treatment
- Disinfect treatment area with chlorhexidine ≥0.5% solution
- Avoid anesthetic agents containing epinephrine
- Patient should avoid anticoagulants 3 days prior
Injection Technique
- Inject at mid-deep dermis depth (1.5-2.5mm)
- Use fanning technique for optimal distribution
- Maintain 30°-45° needle angle
- Maximum 0.2ml per linear threading pass
Post-Treatment Care
- Apply cold compress for 15 minutes post-injection
- Avoid strenuous exercise for 24 hours
- Follow-up at 4-6 week intervals if additional treatment is needed
- Maximum 2ml per treatment session
Important Safety Information
This product is contraindicated for patients with active skin infections, hypersensitivity to Polycaprolactone (PCL), or history of severe allergic reactions. Results may vary depending on individual metabolism, injection technique and biological response. Must be administered by a licensed medical practitioner trained in the product technique. Our company accepts no responsibility for complications resulting from unqualified administration, pre-existing medical conditions, or failure to follow recommended protocols.

Reviews
There are no reviews yet.